Product Information
LOW-OGESTREL-28 TABLET is a generic product labeled by Mayne Pharma, priced at $0.3021 per EA under NDC 51862056406. Its NADAC has been published 526 times since Sep 7, 2016.
FDA first approved this application on Jul 28, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Mayne PharmaNDC
51862056406
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075288FDA Approved
7/28/1999
TE Code
AB
On Market Since
8/3/2016
Price Statistics
The NADAC for LOW-OGESTREL-28 TABLET has been published 526 times since Sep 7, 2016, and over the history we have for it it has declined 41.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3021 per EA |
|---|---|
| All-time high | $0.5540 (Oct 12, 2016) |
| All-time low | $0.2841 (Jul 22, 2026) |
| 52-week high | $0.3813 |
| 52-week low | $0.2841 |
| Median price | $0.4071 |
| Average price | $0.4116 |
| Largest weekly change | +27.0% (Aug 21, 2024) |
| Weeks tracked | 526 |
| Tracking since | Sep 7, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norgestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOW-OGESTREL-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LOW-OGESTREL-28 TABLET, manufactured by Mayne Pharma, is $0.3021 per EA (NDC 51862056406), effective Sep 30, 2026.
How has the price of LOW-OGESTREL-28 TABLET changed over time?
Over the history we have for it, the NADAC for LOW-OGESTREL-28 TABLET has declined 41.7%. It has been tracked across 526 weekly CMS publications since Sep 7, 2016.
What are the highest and lowest recorded NADAC prices for LOW-OGESTREL-28 TABLET?
Since Sep 7, 2016, the NADAC for LOW-OGESTREL-28 TABLET has ranged from a low of $0.2841 (Jul 22, 2026) to a high of $0.5540 (Oct 12, 2016), with a median of $0.4071 per EA.
Are there cheaper alternatives to LOW-OGESTREL-28 TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOW-OGESTREL-28 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LOW-OGESTREL-28 TABLET?
LOW-OGESTREL-28 TABLET (NDC 51862056406) is labeled by Mayne Pharma, and CMS classifies it as a generic product.